EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 12 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $14,000 | -44.0% | 26,800 | +12.6% | 0.00% | 0.0% |
Q1 2018 | $25,000 | 0.0% | 23,800 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $25,000 | -16.7% | 23,800 | -7.8% | 0.00% | 0.0% |
Q3 2017 | $30,000 | +36.4% | 25,800 | +63.3% | 0.00% | 0.0% |
Q2 2017 | $22,000 | -37.1% | 15,800 | +14.5% | 0.00% | -50.0% |
Q1 2017 | $35,000 | +59.1% | 13,800 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $22,000 | -8.3% | 13,800 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $24,000 | – | 13,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,192,000 | $453,000 | 0.04% |
IFP Advisors, Inc | 23,800 | $25,000 | 0.00% |
Holistic Financial Partners | 1,900 | $1,000 | 0.00% |
Vantage Investment Advisors, LLC | 6,500 | $2,000 | 0.00% |
WEDBUSH SECURITIES INC | 20,000 | $8,000 | 0.00% |
US BANCORP \DE\ | 40,650 | $15,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
NORTHERN TRUST CORP | 14,553 | $6,000 | 0.00% |
CREDIT SUISSE AG/ | 26,500 | $10,000 | 0.00% |
MORGAN STANLEY | 7,721 | $3,000 | 0.00% |